Literature DB >> 11922231

Comparative evaluation of market spacer and home made spacer in the management of bronchial asthma.

H K Vatsa, S N Gaur.   

Abstract

INTRODUCTION: A study was conducted to compare the efficacy of market available spacer (with valve) and home made spacer (without valve)--Bislery bottle.
MATERIAL AND METHODS: Fifteen patients of bronchial asthma were included in the study. With the use of both devices there was significant bronchodilator effect. The reversibility using Bislery bottle was same as with spacer (market available) while comparing the FVC, FEV1, FEV1/FVC %, FEF 25-75 and PEFR value. RESULT: The difference in percent change in reversibility values by both the devices was not statistically significant (p < 0.05).
CONCLUSION: We concluded that the Bislery bottle (without valve) is very cheap compared to market-available spacer and is equally effective which, therefore, can be substituted in bronchial asthma patients, who are unable to afford the cost of market available spacers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11922231

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  4 in total

1.  Randomized trial of spacers in asthma.

Authors:  Baljit Dahiya; Joseph L Mathew; Meenu Singh
Journal:  Indian J Pediatr       Date:  2007-07       Impact factor: 1.967

2.  Small Airways Response to Bronchodilators in Adults with Asthma or COPD: A Systematic Review.

Authors:  Mohammed A Almeshari; Nowaf Y Alobaidi; Elizabeth Sapey; Omar Usmani; Robert A Stockley; James A Stockley
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-11-11

Review 3.  Commercial versus home-made spacers in delivering bronchodilator therapy for acute therapy in children.

Authors:  C Rodriguez; M Sossa; J M Lozano
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

4.  Usefulness of Nonvalved Spacers for Administration of Inhaled Steroids in Young Children with Recurrent Wheezing and Risk Factors for Asthma.

Authors:  Carlos Kofman; Alejandro Teper
Journal:  Can Respir J       Date:  2018-09-03       Impact factor: 2.409

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.